Medical transdermal patch
A transdermal patch and adhesive layer technology, applied in the field of medical materials, can solve the problems of adverse skin reactions, skin damage, irritation of the back skin, etc., to improve the transdermal ability, fast onset, and good therapeutic effect. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030]A medicinal transdermal patch, comprising a backing layer, an acrylic pressure-sensitive adhesive layer, a skeleton layer, an organic silicon pressure-sensitive adhesive layer and an anti-adhesive layer from top to bottom, wherein the The skeleton layer is made of the following raw materials in parts by weight: isobornyl acrylate / isopulegol / glycerin monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl chloride 40 parts of imidazole / 6-O-allyl-β-cyclodextrin copolymer, 8 parts of tobramycin, 4 parts of DL-aminocaprolactam amidated alginic acid, 8 parts of azone, 0.01 part of fusion protein, transdermal 1 part of functional Chinese herbal medicine extract.
[0031] The material of the backing layer is a polyurethane film; the material of the anti-adhesive layer is a polyester film whose surface is anti-adhesive treated with silicone oil.
[0032] The isobornyl acrylate / isopulegol / glycerol monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl imidazole ...
Embodiment 2
[0036] A pharmaceutical transdermal patch, comprising a polyester composite film backing layer, a polyacrylate pressure-sensitive adhesive layer, a skeleton layer, a polyurethane pressure-sensitive adhesive layer and a fluoropolymer coating from top to bottom The polyester release layer is characterized in that the skeleton layer is made of the following raw materials in parts by weight: isobornyl acrylate / isopulegol / glycerin monooleate / polyethylene glycol monoallyl ether / 43 parts of 1-allyl-3-methylimidazole chloride / 6-O-allyl-β-cyclodextrin copolymer, 9 parts of sinomenine, 4.5 parts of DL-aminocaprolactam amidated alginic acid, mint 9 parts of alcohol, 0.015 parts of fusion protein, and 1.2 parts of Chinese herbal medicine extract with transdermal function.
[0037] The isobornyl acrylate / isopulegol / glycerol monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl imidazole chloride / 6-O-allyl- The preparation method of β-cyclodextrin copolymer comprises the followi...
Embodiment 3
[0041] A pharmaceutical transdermal patch, which includes an ethylene vinyl acetate film backing layer, a polyacrylate pressure-sensitive adhesive layer, a skeleton layer, a polyurethane pressure-sensitive adhesive layer, and a silicone oil anti-adhesive layer from top to bottom. The treated polyester film anti-adhesive layer is characterized in that the skeleton layer is made of the following raw materials in parts by weight: isobornyl acrylate / isopulegol / glycerin monooleate / polyethylene glycol monoallyl 45 parts of base ether / 1-allyl-3-methyl imidazole chloride / 6-O-allyl-β-cyclodextrin copolymer, 10 parts of metformin hydrochloride, 5 parts of DL-aminocaprolactam amidated alginic acid , 10 parts of urea, 0.02 parts of fusion protein, and 1.5 parts of Chinese herbal medicine extract with transdermal function.
[0042] The isobornyl acrylate / isopulegol / glycerol monooleate / polyethylene glycol monoallyl ether / 1-allyl-3-methyl imidazole chloride / 6-O-allyl- The preparation method...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com